These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10885356)

  • 1. Malaria chemoprophylaxis with tafenoquine: a randomised study.
    Lell B; Faucher JF; Missinou MA; Borrmann S; Dangelmaier O; Horton J; Kremsner PG
    Lancet; 2000 Jun; 355(9220):2041-5. PubMed ID: 10885356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.
    Lell B; Luckner D; Ndjavé M; Scott T; Kremsner PG
    Lancet; 1998 Mar; 351(9104):709-13. PubMed ID: 9504515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.
    Shanks GD; Oloo AJ; Aleman GM; Ohrt C; Klotz FW; Braitman D; Horton J; Brueckner R
    Clin Infect Dis; 2001 Dec; 33(12):1968-74. PubMed ID: 11700577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
    Hale BR; Owusu-Agyei S; Fryauff DJ; Koram KA; Adjuik M; Oduro AR; Prescott WR; Baird JK; Nkrumah F; Ritchie TL; Franke ED; Binka FN; Horton J; Hoffman SL
    Clin Infect Dis; 2003 Mar; 36(5):541-9. PubMed ID: 12594633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
    Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants.
    Menendez C; Kahigwa E; Hirt R; Vounatsou P; Aponte JJ; Font F; Acosta CJ; Schellenberg DM; Galindo CM; Kimario J; Urassa H; Brabin B; Smith TA; Kitua AY; Tanner M; Alonso PL
    Lancet; 1997 Sep; 350(9081):844-50. PubMed ID: 9310602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries.
    Dow GS; Liu J; Lin G; Hetzell B; Thieling S; McCarthy WF; Tang D; Smith B
    Malar J; 2015 Nov; 14():473. PubMed ID: 26610844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.
    Walsh DS; Eamsila C; Sasiprapha T; Sangkharomya S; Khaewsathien P; Supakalin P; Tang DB; Jarasrumgsichol P; Cherdchu C; Edstein MD; Rieckmann KH; Brewer TG
    J Infect Dis; 2004 Oct; 190(8):1456-63. PubMed ID: 15378438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Schizonticidal Activity and Safety of Tafenoquine When Administered as Chemoprophylaxis to Healthy, Nonimmune Participants Followed by Blood Stage Plasmodium falciparum Challenge: A Randomized, Double-blind, Placebo-controlled Phase 1b Study.
    McCarthy JS; Smith B; Reid M; Berman J; Marquart L; Dobbin C; West L; Read LT; Dow GS
    Clin Infect Dis; 2019 Jul; 69(3):480-486. PubMed ID: 30388194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
    von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T
    Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future.
    Shanks GD; Kain KC; Keystone JS
    Clin Infect Dis; 2001 Aug; 33(3):381-5. PubMed ID: 11438908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
    Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approval of Tafenoquine for Malaria Chemoprophylaxis.
    Berman JD
    Am J Trop Med Hyg; 2019 Jun; 100(6):1301-1304. PubMed ID: 30887947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific.
    Elmes NJ; Nasveld PE; Kitchener SJ; Kocisko DA; Edstein MD
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1095-101. PubMed ID: 18541280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects.
    Charles BG; Miller AK; Nasveld PE; Reid MG; Harris IE; Edstein MD
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2709-15. PubMed ID: 17517850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects.
    Nasveld PE; Edstein MD; Reid M; Brennan L; Harris IE; Kitchener SJ; Leggat PA; Pickford P; Kerr C; Ohrt C; Prescott W;
    Antimicrob Agents Chemother; 2010 Feb; 54(2):792-8. PubMed ID: 19995933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a 3-day pretravel schedule of tafenoquine for malaria chemoprophylaxis: a network meta-analysis.
    Islam N; Wright S; Lau CL; Doi SAR; Mills DJ; Clark J; Clements ACA; Furuya-Kanamori L
    J Travel Med; 2021 Jul; 28(5):. PubMed ID: 33834208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force.
    Edstein MD; Walsh DS; Eamsila C; Sasiprapha T; Nasveld PE; Kitchener S; Rieckmann KH
    Med Trop (Mars); 2001; 61(1):56-8. PubMed ID: 11584657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
    Aponte JJ; Schellenberg D; Egan A; Breckenridge A; Carneiro I; Critchley J; Danquah I; Dodoo A; Kobbe R; Lell B; May J; Premji Z; Sanz S; Sevene E; Soulaymani-Becheikh R; Winstanley P; Adjei S; Anemana S; Chandramohan D; Issifou S; Mockenhaupt F; Owusu-Agyei S; Greenwood B; Grobusch MP; Kremsner PG; Macete E; Mshinda H; Newman RD; Slutsker L; Tanner M; Alonso P; Menendez C
    Lancet; 2009 Oct; 374(9700):1533-42. PubMed ID: 19765816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tafenoquine: a promising new antimalarial agent.
    Crockett M; Kain KC
    Expert Opin Investig Drugs; 2007 May; 16(5):705-15. PubMed ID: 17461742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.